Bestyrelsen
Novo Nordisk Fondens bestyrelse består af ni medlemmer, hvoraf seks er vedtægtsvalgte og tre er medarbejdervalgte bestyrelsesmedlemmer. De vælges for hhv. et og fire år ad gangen. Bestyrelsen har udarbejdet en kompetenceprofil, der beskriver de foretrukne kompetencer i bestyrelsen.
Lars Rebien Sørensen
Bestyrelsesformand
Lars Munch
Næstformand
Christopher A. Voigt
Medlem
Jakob Müller
Medlem
Lars Fugger
Medlem
Mads Grøn
Medlem
Nana Bule Sejbæk
Medlem
Liselotte Højgaard
Medlem
Steen Riisgaard
Medlem
Stig Strøbæk
Medlem
Vores ledelse
Mads Krogsgaard Thomsen
Chief Executive Officer, Professor, DVM, PhD, DSc
Søren Nedergaard
Chief Operating Officer
Erika Söderberg Johnsson
Chief Financial Officer
Steffen P. Lüders
Senior Vice President, Corporate Affairs
Claus Felby
Senior Vice President, Biotech, Professor, PhD
Lene Oddershede
Senior Vice President, Natural & Technical Sciences, Professor
Martin Ridderstråle
Senior Vice President, Medical Science, Chief Medical Officer
Berith Bjørnholm
Senior Vice President, Education & Outreach, PhD
Arne Astrup
Senior Vice President, Obesity and Nutritional Sciences, professor, MD, DMSc
Peter Lawætz Andersen
Senior Vice President, Infectious Diseases, Professor, DVM, DSc
Thomas Alslev Christensen
Senior Vice President, Impact, PhD
Mikkel Skovborg
Senior Vice President, Innovation
Flemming Konradsen
Senior Vice President, Social & Humanitarian
Pelle Munk-Poulsen
General Counsel & Senior Vice President, Legal
Stine Fehmerling
Senior Vice President, People & Organisation
Sofie Singbrant Söderberg
Director, Head of Project & Portfolio Management, PhD
Anne Kahr Hällman
Director, Grant Management, PhD